Gerresheimer (GXI) PT Set at €55.00 by Hauck & Aufhaeuser

Hauck & Aufhaeuser set a €55.00 ($67.90) price objective on Gerresheimer (ETR:GXI) in a research report report published on Friday morning. The firm currently has a sell rating on the stock.

Several other research analysts have also recently issued reports on the stock. Berenberg Bank set a €75.00 ($92.59) target price on shares of Gerresheimer and gave the company a buy rating in a report on Friday, December 8th. Goldman Sachs Group set a €68.00 ($83.95) target price on shares of Gerresheimer and gave the company a neutral rating in a report on Thursday, January 25th. JPMorgan Chase & Co. set a €87.70 ($108.27) target price on shares of Gerresheimer and gave the company a buy rating in a report on Tuesday, February 6th. Independent Research set a €74.00 ($91.36) target price on shares of Gerresheimer and gave the company a neutral rating in a report on Thursday, January 25th. Finally, Deutsche Bank set a €64.00 ($79.01) target price on shares of Gerresheimer and gave the company a neutral rating in a report on Friday, December 1st. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the company. The stock presently has a consensus rating of Hold and an average target price of €69.58 ($85.90).

Shares of Gerresheimer (ETR GXI) traded down €1.35 ($1.67) during trading on Friday, hitting €60.90 ($75.19). 274,270 shares of the stock traded hands, compared to its average volume of 121,723. Gerresheimer has a fifty-two week low of €59.97 ($74.04) and a fifty-two week high of €78.25 ($96.60). The firm has a market cap of $1,910.00 and a PE ratio of 18.97.

TRADEMARK VIOLATION WARNING: “Gerresheimer (GXI) PT Set at €55.00 by Hauck & Aufhaeuser” was first reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://www.thelincolnianonline.com/2018/02/24/gerresheimer-gxi-pt-set-at-55-00-by-hauck-aufhaeuser.html.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply